Alfonzo Leon
CIK 1647511 · View on SEC EDGAR ↗
First SEC filing: March 3, 2021 · Latest: March 3, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | XRN | A | 3,273 | — | — | 105,115 Direct | +3.21% | Acquired | (price as of 2026-08-20) |
| Feb. 24, 2026 | XRN | A | 10,385 | — | — | 101,842 Direct | +11.36% | Acquired | (price as of 2026-08-20) |
| Feb. 26, 2025 | XRN | A | 12,650 | — | — | 457,283 Direct | +2.85% | Acquired | (price as of 2026-08-20) |
| Feb. 26, 2025 | XRN | A | 46,069 | — | — | 444,633 Direct | +11.56% | Acquired | (price as of 2026-08-20) |
| Feb. 21, 2024 | XRN | A | 15,742 | — | — | 398,564 Direct | +4.11% | Acquired | (price as of 2026-08-20) |
| Feb. 21, 2024 | XRN | A | 38,860 | — | — | 382,822 Direct | +11.30% | Acquired | (price as of 2026-08-20) |
| Feb. 28, 2023 | XRN | A | 7,094 | — | — | 343,962 Direct | +2.11% | Acquired | (price as of 2026-08-20) |
| Feb. 23, 2023 | XRN | A | 27,422 | — | — | 336,868 Direct | +8.86% | Acquired | (price as of 2026-08-20) |
| March 4, 2022 | XRN | A | 25,290 | — | — | 309,446 Direct | +8.90% | Acquired | (price as of 2026-08-20) |
| Feb. 28, 2022 | XRN | A | 9,359 | — | — | 284,156 Direct | +3.41% | Acquired | (price as of 2026-08-20) |
| Feb. 24, 2022 | XRN | A | 9,905 | — | — | 274,797 Direct | +3.74% | Acquired | (price as of 2026-08-20) |
| May 26, 2021 | XRN | A | 6,519 | — | — | 264,892 Direct | +2.52% | Acquired | (price as of 2026-08-20) |
| March 2, 2021 | XRN | A | 36,740 | — | — | 258,373 Direct | +16.58% | Acquired | (price as of 2026-08-20) |
| March 2, 2021 | XRN | A | 26,940 | — | — | 221,633 Direct | +13.84% | Acquired | (price as of 2026-08-20) |
| July 9, 2020 | XRN | A | 71,702 | — | — | 194,693 Direct | +58.30% | Acquired | (price as of 2026-08-20) |
| March 3, 2020 | XRN | A | 25,974 | — | — | 122,991 Direct | +26.77% | Acquired | (price as of 2026-08-20) |
| March 3, 2020 | XRN | A | 5,857 | — | — | 97,017 Direct | +6.42% | Acquired | (price as of 2026-08-20) |
| March 3, 2020 | XRN | A | 16,832 | — | — | 91,160 Direct | +22.65% | Acquired | (price as of 2026-08-20) |
| March 5, 2019 | XRN | A | 3,125 | — | — | 74,328 Direct | +4.39% | Acquired | (price as of 2026-08-20) |
| March 5, 2019 | XRN | A | 8,342 | — | — | 71,203 Direct | +13.27% | Acquired | (price as of 2026-08-20) |
| March 5, 2019 | XRN | A | 12,765 | — | — | 62,861 Direct | +25.48% | Acquired | (price as of 2026-08-20) |
| March 5, 2018 | XRN | A | 12,140 | — | — | 50,096 Direct | +31.98% | Acquired | (price as of 2026-08-20) |
| March 5, 2018 | XRN | A | 8,182 | — | — | 37,956 Direct | +27.48% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (3,492) | — | — | 3,273 | Acquired |
| Feb. 24, 2026 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (10,385) | — | — | 10,385 | Acquired |
| Feb. 26, 2025 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (12,650) | — | — | 12,650 | Acquired |
| Feb. 26, 2025 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (46,069) | — | — | 46,069 | Acquired |
| Feb. 21, 2024 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (15,742) | — | — | 15,742 | Acquired |
| Feb. 21, 2024 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (38,860) | — | — | 38,860 | Acquired |
| Feb. 28, 2023 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (7,094) | — | — | 7,094 | Acquired |
| Feb. 23, 2023 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (27,422) | — | — | 27,422 | Acquired |
| March 4, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (25,290) | — | — | 25,290 | Acquired |
| Feb. 28, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (9,359) | — | — | 9,359 | Acquired |
| Feb. 24, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (9,905) | — | — | 9,905 | Acquired |
| May 26, 2021 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (6,519) | — | — | 6,519 | Acquired |
| March 2, 2021 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (36,740) | — | — | 36,740 | Acquired |
| March 2, 2021 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (26,940) | — | — | 26,940 | Acquired |
| July 9, 2020 | XRN | LTIP Unit [F1] | Common Stock (71,702) | — | — | 71,702 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock (25,974) | — | — | 25,974 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (5,857) | — | — | 5,857 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (16,832) | — | — | 16,832 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F5] | Common Stock (3,125) | — | — | 3,125 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock (8,342) | — | — | 8,342 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (12,765) | — | — | 12,765 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock (12,140) | — | — | 12,140 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (8,182) | — | — | 8,182 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $375,000 | — | $750,000 | — | $214,875 | — | — | $1,339,875 |
| 2021 | $310,000 | — | $344,000 | — | $189,511 | — | — | $843,511 |
| 2018 | — | — | $324,983 | — | — | — | — | $367,542 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.